NEW YORK (GenomeWeb News) – CompanionDx Reference Lab and Enable Healthcare have partnered to provide physicians in Enable's network access to CompanionDx's pharmacogenomics testing.

Enable's physicians will use CompanionDx's services to make better informed decisions about patient therapies and medications and to identify poor and ultra-rapid metabolizers of drugs, CompanionDx said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.